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Abstract. 
 
The 21 nucleotide RNA trafﬁcking signal 
(RTS), originally identiﬁed in myelin basic protein 
mRNA, but also found in a variety of other localized 
RNAs, is necessary and sufﬁcient for transport of RNA 
along microtubules in oligodendrocytes. The RTS binds 
speciﬁcally to the RNA binding protein, hnRNP A2. 
Together, the RTS and hnRNP A2 comprise cis
 
/
 
trans 
determinants for several steps in the RNA trafﬁcking 
pathway. Here we show that insertion of the RTS into 
green ﬂuorescent protein (GFP) RNA enhances trans-
lation without affecting stability of microinjected RNA. 
In dicistronic RNA, the RTS enhances cap-dependent 
translation without affecting internal ribosome entry 
site (IRES)-dependent translation. The translation en-
hancer function of the RTS is position, copy number, 
and cell type independent, hnRNP A2 dependent, and 
saturable with increasing amounts of injected RNA. 
This represents one of the ﬁrst speciﬁc translation en-
hancer elements identiﬁed in a mammalian system.
Key words: translation enhancer • hnRNP A2 • RNA 
trafﬁcking signal • dicistronic RNA • eIF4E
 
E
 
UCARYOTIC
 
 mRNAs follow defined intracellular
trafficking pathways from their sites of transcrip-
tion to their sites of translation (Dreyfuss et al.,
1996). The pathway for each mRNA is determined by spe-
cific cis-acting sequence elements within the RNA and by
cognate trans-acting factors in the cell (McCarthy and Koll-
mus, 1995; Gavis, 1997). Specific cis
 
/
 
trans determinants for
RNA trafficking have been identified for RNAs encoding
actin (Ross et al., 1997), bicoid (Macdonald and Struhl,
1988; Macdonald et al., 1993), nanos (Gavis et al., 1996b),
oskar (Ephrussi and Lehmann, 1992; Kim-Ha et al., 1993),
Vg-1 (Mowry and Melton, 1992; Deshler et al., 1997), and
myelin basic protein (MBP)
 
1
 
 (Ainger et al., 1997; Hoek et
al., 1998).
Translation regulation plays an integral role in the RNA
trafficking pathway. Translation is thought to be repressed
while the RNA is in transit and activated once the RNA is
localized. This steers expression of specific gene products
to spatially restricted regions of the cell where the RNA is
localized, and minimizes ectopic expression elsewhere in
the cell. A variety of general mRNA structural features
such as the 5
 
9
 
 cap (Svitkin et al., 1996), 3
 
9
 
 poly A tail
(Hentze, 1995), Kozak consensus sequence (Kozak, 1989),
internal ribosome entry sites (IRES) (Sachs et al., 1997),
and AU rich elements (ARE) (Zhou et al., 1997) affect
translational efficiency. In 
 
Drosophila
 
, multiple factors
regulating translation during development have been
identified genetically (Wilson et al., 1996; Seydoux, 1996),
and specific cis
 
/
 
trans determinants for translation suppres-
sion have been identified biochemically (Simbert et al.,
1996; Dahanukar and Wharton, 1996; Gavis et al., 1996a).
Recently, motifs with translation enhancer activity have
been identified in the 5
 
9
 
UTR of 
 
Arabidopsis 
 
ferredoxin
gene, 
 
fed A
 
, and a photosystem I gene, 
 
psaDb
 
, of
 
 Nicoti-
ana sylvestris
 
 (Yamamoto et al., 1995). However, few spe-
cific cis
 
/
 
trans determinants for translation regulation have
been identified in mammalian systems. The work de-
scribed here provides evidence that a specific cis-acting
RNA trafficking sequence (RTS) and its cognate trans-
acting ligand (hnRNP A2), originally identified as cis
 
/
 
trans
determinants for transport of MBP mRNA in oligoden-
drocytes, also function to enhance translation in mamma-
lian systems.
The oligodendrocyte is the cell that elaborates myelin in
the CNS (Bunge et al., 1962). MBP is a major structural
component of the myelin membrane (Mikoshiba et al.,
1991) and is required for major dense line formation dur-
ing myelin compaction. The unique topology of the oli-
godendrocyte has facilitated elucidation of intracellular
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RNA trafficking because the different steps in the path-
way are confined to spatially resolvable subcellular com-
partments (Ainger et al., 1993). Nuclear export occurs at
the nuclear envelope, assembly of RNA into granules oc-
curs in the perikaryon, RNA transport occurs along micro-
tubules in the processes and veins, and RNA localization
and translation activation occur in the myelin compart-
ment. Deletion mapping and microinjection experiments
with chimeric RNAs have delineated a 21-nucleotide
RNA trafficking sequence (RTS) in the 3
 
9
 
UTR of MBP
mRNA that is necessary and sufficient for RNA transport
in oligodendrocytes (Ainger et al., 1997). RTS-like se-
quences are also found in a variety of other RNAs that are
localized in other cell types, suggesting that the RTS is a
general RNA trafficking signal. In vitro binding experi-
ments indicate that the RTS binds with sequence specific-
ity and high affinity to hnRNP A2, a ubiquitously ex-
pressed RNA binding protein that is believed to play a
role in intracellular RNA trafficking (Hoek et al., 1998).
The RTS and hnRNP A2 comprise cis
 
/
 
trans determinants
for multiple steps in trafficking of MBP mRNA in oligo-
dendrocytes and perhaps of RTS-containing RNAs in
other cell types as well (Carson et al., 1998). The work de-
scribed here was undertaken to determine if RTS/A2 de-
terminants also function to regulate translation.
In eucaryotic cells, translation is often regulated at the
initiation stage (Hentze, 1995; Jackson and Wickens,
1997). There are two mechanisms of translation initiation,
cap dependent and internal ribosome entry site (IRES)
dependent (Sachs et al., 1997). The two mechanisms use
exactly the same molecular machinery (Sachs et al., 1997),
except that cap-dependent initiation requires a 5
 
9 
 
cap on
the mRNA (Svitkin et al., 1996) and cap-binding protein
(eIF4E) in the cell (Jackson and Wickens, 1997), whereas
IRES-dependent initiation requires an IRES within the
mRNA and an IRES-binding protein (possibly La au-
toantigen) in the cell (Svitkin et al., 1994). In this work,
we examined the effect of the RTS on both cap-depen-
dent and IRES-dependent translation. The RTS en-
hanced cap-dependent translation specifically and the ef-
fect was position, copy number, and cell type independent
and hnRNP A2 dependent and saturable with increasing
amounts of RNA.
 
Materials and Methods
 
Cell Culture
 
Neuroblastoma B104 cells and CHO cells were grown in 6% newborn
calf serum in DME. Oligodendrocytes from shiverer mice were isolated
after 12–14 d of growth in culture as described previously (Ainger et al.,
1993).
 
Reagents
 
Restriction enzymes and RNA polymerase were obtained from New En-
gland BioLabs, Promega, Stratagene, and Epicentre Technologies. RNA
and protein molecular markers were obtained from GIBCO BRL. Texas
red–conjugated dextran (TRD) was obtained from Molecular Probes,
Inc. Rabbit polyclonal antibody to ribophorin I (9R1) was obtained from
R. Gould (New York State Institute for Basic Research and Develop-
mental Disabilities, Staten Island, NY). Characterization of antibody
9R1 is described in Kreibich et al., 1983. Mouse monoclonal antibody to
hnRNP A2 (EF-67) was obtained from W. Rigby (Dartmouth Medical
School, Lebanon, NH). Recombinant hnRNP A2 was obtained from R.
Smith (University of Queensland, Queensland, AU).
 
Recombinant DNA and In Vitro Transcription
 
Full-length cDNA for S65T mutant GFP cloned in pRSETB, was ob-
tained from Dr. R.Y. Tsien (University of California, San Diego, CA).
pGEM1A, containing the SP6 promoter and poly A, was obtained from
Dr. G. Carmichael (University of Connecticut Health Center, Farm-
ington, CT). The entire S65T mutant GFP cDNA was subcloned into
the BamH1 site of pGEM1A to create pGFP
 
9
 
A. The RTS sequence
(GCCAAGGAGCCAGAGAGCATG) was inserted into AvaI/SacI cut
pGFP
 
9
 
A and HindIII-XbaI cut pGFP
 
9
 
A to create pGFP
 
9
 
3RTS and
pGFP
 
9
 
5RTS, respectively. To create pGFP
 
9
 
53RTS, the RTS was inserted
into both AvaI-SacI and HindIII-XbaI cut pGFP
 
9
 
A. To create dicistronic
constructs, full-length cDNA for BFP, cloned in pQBI50 purchased from
Quantum Biotechnologies Inc., was amplified by PCR using oligonucle-
otides that placed XbaI and XmaI cloning sites at the 5
 
9
 
 and 3
 
9
 
 ends, re-
spectively, and then was inserted into XbaI-XmaI cut pGFP
 
9
 
A and
pGFP3
 
9
 
RTS to replace the GFP ORF with the BFP ORF, creating pBFP
and pBFP3
 
9
 
RTS. The IRES from EMCV and S65T GFP ORF cloned in
pTR5-DC/GFP (a kind gift from D.D. Moser, Biotechnology Research In-
stitute, Montreal, Canada) were amplified by PCR using oligonucleotides
that placed XmaI cloning sites at both 5
 
9
 
 and 3
 
9
 
 ends, and then was in-
serted into XmaI cut pBFP and pBFP3
 
9
 
RTS to create pBDCG and
pBDCG3R, respectively.
GFP mRNA and GFP/RTS mRNA, containing the RTS in the 3
 
9
 
UTR,
5
 
9
 
UTR, or both, were prepared by in vitro transcription using Ampli-
Scribe SP6 Transcription Kits (Epicentre Technologies) using pGFP
 
9
 
A,
pGFP
 
9
 
3RTS, pGFP
 
9
 
5RTS, and pGFP
 
9
 
53RTS, linearized with SapI as
template DNA, and m7G(5
 
9
 
)ppp(5
 
9
 
)G added to the transcription mixture
to produce capped mRNAs.
 
Translation Assays
 
To assay translation in vivo, capped GFP
 
9
 
A mRNA and GFP
 
9
 
3RTS
mRNA at equivalent concentrations were microinjected into neuroblas-
toma B104 cells, CHO cells, or shiverer oligodendrocytes as described
previously (Ainger et al., 1993). TRD was coinjected to provide a measure
of the injected volume. Injected cells were incubated at 37
 
8
 
C for 20–24 h.
The expressed GFP/TRD fluorescence was visualized by dual channel
confocal microscopy, using a Zeiss LSM 410 confocal laser scanning sys-
tem (Zeiss) with an infinity-corrected 60
 
3
 
 1.4 NA objective. Unless other-
wise indicated, images were collected within the dynamic range of the
frame store such that pixel values outside the cell were 
 
.
 
0 and pixel val-
ues inside the cell were 
 
,
 
255. GFP and TRD pixel values were integrated
over the nucleus to avoid autofluorescent signal in the cytoplasm. The
concentration of injected RNA in each cell was calculated based on the
initial concentration of RNA and TRD in the pipet and the integrated
TRD pixel values in the nucleus. Translation efficiencies were determined
by calculating the GFP/RNA ratio for each cell.
To assay translation in vitro, nuclease-treated rabbit reticulocyte lysate
and wheat germ extracts were purchased from Promega and reactions
were performed according to the manufacturer’s instructions. Translation
was monitored by [S
 
35
 
]methionine (Amersham) incorporation. Transla-
tion products were separated by 12% SDS-PAGE. After electrophoresis,
the gels were fixed, soaked in EN
 
3
 
HANCE (New England Nuclear),
dried, and subjected to autoradiography to visualize labeled GFP
polypeptide. The intensities of specific bands were integrated using Im-
ageQuaNT.
 
Dequenching Assay for RNA Stability
 
Fluorescein-labeled GFP RNA and GFP/3
 
9
 
RTS RNA, prepared as previ-
ously described (Kwon and Carson, 1998), were microinjected into the cy-
toplasm of neuroblastoma B104 cells. Images of injected cells were col-
lected with a cooled CCD camera at 10-min intervals. Total intracellular
fluorescence intensities were integrated using the ImageQuaNT program.
 
Antisense Oligonucleotide Treatment of B104
Cell Cultures
 
B104 cells or oligodendrocytes were incubated in defined culture medium
containing 8 
 
m
 
M final concentration of phosphorothioate oligonucleotide
obtained from the Molecular Core at UCHC) as described previously
(Carson et al., 1997). The media containing the oligonucleotide was
changed every 8 h for a period of 24 h. Antisense oligonucleotide
(CTTTTCTCTCTCCATCGCGGA) was complementary to a region 
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around the translation start site of human hnRNP A2 mRNA. The corre-
sponding sense oligonucleotide was used as a control. Expression of
hnRNP A2 in oligodendrocytes was evaluated by immunofluorescence
(IF) using monoclonal antibody to hnRNP (1:100). Expression of hnRNP
A2 in B104 cells was evaluated by Western blotting with antibody to
hnRNP A2 (1:1,000) and rabbit polyclonal antibody to ribophorin I (1:
1,000) as a control for loading.
 
RNA Transport Assay
 
The NaeI-HindIII fragment from pBluescript SK II(
 
1
 
) was inserted into
NaeI-HindIII cut pGFP
 
9
 
A and pGFP
 
9
 
A/3
 
9
 
RTS to create pGT7 and
pG3RT7, respectively. Digoxigenin-labeled GFP mRNA and GFP/3
 
9
 
RTS
mRNA were generated by in vitro transcription using BsaWI cut pGT7
and pG3RT7 as a template. The RNA transport assay was performed as
previously described (Ainger et al., 1993; Carson et al., 1997).
 
Results
 
The RTS Is a Translation Enhancer
 
A translation enhancer is a cis-acting RNA sequence that
increases the translation efficiency of the mRNA contain-
ing it. Translation efficiency is a measure of the amount of
protein translated from a certain amount of RNA. To de-
termine translation efficiency for a particular RNA in
vivo, it is necessary to measure both the concentration of
that RNA and the amount of protein expressed from it in
individual cells. Conventional transfection techniques are
of limited use for this purpose because the amount of
DNA or RNA introduced or expressed is variable and dif-
ficult to measure in individual cells. In some cells, the level
of RNA may be saturating, in which case the rate of trans-
lation may be determined not by the concentration of
RNA but by the activity of rate limiting components of the
translation machinery (such as eIF4E) in the cell. There-
fore, translation efficiency can only be accurately mea-
sured in cells where the exogenous RNA is present in the
cell at subsaturating concentrations. Furthermore, cells
with saturating levels of RNA generally have high levels of
protein expression and, therefore, a disproportionate con-
tribution to the level of protein expression measured for
the population as a whole. This tends to obscure the con-
tribution of cells with subsaturating levels of RNA and
lower levels of protein expression which are the very cells
that are informative for determining translation efficiency
for a particular RNA. For these reasons it was necessary to
develop a method to introduce subsaturating amounts of
RNA into cells and to measure both RNA concentrations
and protein translation levels in individual cells.
A ratiometric translation efficiency assay was developed
using mRNA encoding green fluorescent protein (GFP)
from 
 
Aequorea victoria
 
 as a reporter for translation and
TRD (10 kD) as a reporter for the volume of microin-
jected RNA. Capped, polyadenylated mRNA encoding
GFP was coinjected with TRD into the cytoplasm of B104
cells which were used instead of oligodendrocytes because
they lack long processes so that translation of the injected
RNA can be analyzed without the confounding variable of
RNA transport. After incubation to allow time for GFP
expression, injected cells were analyzed by dual channel
confocal microscopy. TRD dispersed rapidly throughout
the cytoplasm and nucleus, and total fluorescent intensity
in each cell remained constant over 24 h (data not shown).
GFP, which also dispersed throughout the cytoplasm and
 
nucleus, was first detected by 2 h after injection, increased
to a maximum by 9 h, and remained constant up to 24 h
(data not shown). The relative amount of RNA injected
into each cell was calculated based on the integrated TRD
fluorescence intensity in the injected cell. The amount of
GFP expression was quantified by integrating GFP fluo-
rescence intensity. Since both TRD and GFP enter the nu-
cleus by diffusion, fluorescence intensities were integrated
in optical sections through the nucleus to avoid autofluo-
rescent signal from the cytoplasm. The intensity of TRD
fluorescence in each cell provides a measure of the volume
of RNA injected. The intensity of GFP fluorescence pro-
vides a measure of the amount of protein translated from
the injected RNA. The ratio of GFP to RNA provides a
measure of the translation efficiency in each cell.
The RTS is a cis-acting sequence that mediates intracel-
lular trafficking of MBP and other mRNAs in oligoden-
drocytes. To determine its effect on translation efficiency
the RTS was inserted into the 3
 
9
 
UTR of GFP. Representa-
tive cells injected with GFP/RTS RNA or GFP RNA are
shown in Fig. 1. The intensity in the red channel (which
measures TRD concentration which is proportional to
RNA concentration) was comparable in the cells injected
with GFP/RTS RNA and GFP RNA (Fig. 1 A, i and ii) in-
dicating that comparable volumes of RNA were injected
into these cells. The intensity in the green channel (which
measures GFP concentration) was greater in the cells in-
jected with GFP/RTS RNA compared with cells injected
with GFP RNA (Fig. 1 A, iii and iv), indicating that the
RTS increases GFP expression. The values for intracellu-
lar RNA concentration (in nM) and GFP (expressed in ar-
bitrary fluorescence intensity units) obtained from multi-
ple individual cells are shown in Fig 1 B. Overall, the level
of GFP expression was greater in cells injected with GFP/
RTS RNA compared with cells injected with GFP RNA.
There was considerable variability in both the amount of
RNA injected and the level of GFP expression per cell.
Some of the variability in GFP expression may reflect in-
jection of RNA into subcellular compartments with differ-
ent translational activities. For example, RNA injected
into the nucleus is not efficiently exported to the cyto-
plasm and, therefore, not translated efficiently.
To quantify translation efficiency the ratio of GFP/RNA
was calculated and plotted versus the amount of injected
RNA for each cell. Fig. 1 C shows translation efficiencies
for cells injected with different amounts of GFP/RTS
RNA and GFP RNA. In cells injected with GFP RNA,
translation efficiency was relatively constant (mean trans-
lation efficiency 
 
5 
 
1.0 
 
6
 
 0.3) over a wide range of injected
RNA, indicating that the endogenous translation machin-
ery in the cell is not saturated by the injected RNA. Cells
injected with very low levels of GFP RNA (
 
,
 
5 nM) ex-
pressed very low levels of GFP. In some cases the level of
GFP expression, while detectable, was too low to quantify
accurately. These cells were not included in the graph. In
cells injected with low amounts of GFP/RTS RNA (
 
,
 
5 nM),
translation efficiency was enhanced (
 
.
 
10-fold in several
cells and up to 16-fold in one cell) relative to GFP RNA.
At higher amounts of injected RNA (
 
.
 
10 nM), translation
efficiency for GFP/RTS RNA was comparable to GFP
RNA. These results indicate that the RTS enhances ex-
pression of GFP mRNA at low RNA concentrations but 
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the enhancer function is saturated at high RNA concen-
trations suggesting that RTS-mediated enhanced expres-
sion requires component(s) that are present in limiting
amounts in the injected cells.
Increased GFP expression mediated by the RTS could
be due to either enhanced translation efficiency or en-
hanced RNA stability in the injected cells. To measure the
relative stabilities of GFP/RTS RNA and GFP mRNA in
microinjected cells, a novel in vivo fluorescence dequench-
ing assay (Kwon and Carson, 1998) was used. Fluorescein-
UTP was incorporated by in vitro transcription into the
body of GFP/RTS and GFP RNA. In the intact RNA, flu-
orescence is reduced by intramolecular quenching be-
tween proximate fluorophores. The fluorescently labeled
RNA was microinjected into cells and intracellular fluo-
rescence was measured as a function of time after injec-
tion. In this assay, degradation of the fluorescent RNA
causes an increase in total fluorescence due to relief of
intramolecular quenching (dequenching) in the injected
RNA. Complete degradation of the RNA results in an in-
crease of 
 
z
 
50% in the fluorescent quantum yield due to
dequenching. The amount of dequenching provides a mea-
sure of the intracellular stability of the injected RNA. As
shown in Fig. 2, there was no significant dequenching over
a period of 40 min after injection with either GFP/RTS
RNA or GFP RNA, indicating that the two RNAs are
both relatively stable within this time frame. The assay was
not extended beyond 40 min because translation of the in-
jected RNA could produce GFP fluorescence that would
interfere with measurement of the injected fluorescein-
labeled RNA. The dequenching assay provides a measure
of the rate of RNA degradation in the cell in the time period
immediately after injection. Since there is a lag of up to 4 h
between synthesis of GFP and appearance of GFP fluores-
cence in the cell, and since most accumulation of GFP flu-
orescence occurs within a few hours after injection, it
follows that overall accumulation of GFP fluorescence re-
flects GFP translation within the first few hours after in-
jection. Since there was no detectable difference in stabil-
ity between GFP RNA and GFP/RTS RNA in the period
immediately after injection, it is unlikely that the differen-
tial GFP expression observed with GFP/RTS RNA com-
pared with GFP RNA is attributable to differences in ini-
tial RNA stability. Therefore, increased GFP expression
must be due to enhanced translation efficiency mediated
by the RTS.
 
The Translation Enhancer Function of the RTS Is 
Position, Copy Number, and Cell Type Independent
 
To determine if the translation enhancer function of the
RTS is dependent on its position in the mRNA, chimeric
GFP mRNAs were synthesized containing the RTS in-
 
Figure 1.
 
Ratiometric translation assay for GFP RNA and GFP/
RTS RNA. (A) Dual channel confocal images of B104 neuro-
blastoma cells microinjected with a mixture of TRD and either
GFP RNA (i and iii) or GFP/RTS RNA (ii and iv). After 24 h,
the cells were imaged by dual channel confocal microscopy. i and
ii show TRD images. iii and iv show GFP images. Bar, 10 
 
m
 
m. (B)
GFP and TRD fluorescence in cells injected with GFP RNA
(open circles) or GFP/RTS RNA (closed circles). For each cell
the pixel values in the GFP and TRD channels were integrated
over the nuclear area. TRD intensity provides a measure of the
injected volume, from which the intracellular RNA concentra-
tion was calculated. GFP intensity provides a measure of GFP ex-
pression (in arbitrary units). (C) Translation efficiency in cells in-
jected with GFP RNA (open circles) or GFP/RTS RNA (closed
circles). The ratio of GFP to RNA is plotted versus the RNA
concentration as a measure of the translation efficiency in each
cell. 
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serted into either the 3
 
9
 
UTR, the 5
 
9
 
UTR, or both. Because
there is an AUG within the RTS, insertion into the 5
 
9
 
UTR
of GFP RNA may change the translation initiation site
which could result in a 10–amino acid extension at the
NH
 
2
 
 terminus of GFP. NH
 
2
 
-terminal extensions do not
generally affect GFP fluorescence (Rizzuto et al., 1996;
Miyawaki et al., 1997). Chimeric RNAs were microin-
jected into B104 cells and translation efficiencies were
determined at subsaturating RNA concentrations as de-
scribed in Fig. 1 (Table I). Translation was enhanced 4.19-
fold with the RTS in the 3
 
9
 
UTR, 4.82-fold in the 5
 
9
 
UTR,
and 3.27-fold with copies in both the 3
 
9
 
 and 5
 
9
 
UTRs. This
indicates that the translation enhancer function of the
RTS is position and copy number independent. The mar-
ginal decrease in translation enhancer activity with two
copies of the RTS compared with a single copy may be due
to titration of some limiting factor required for enhanced
translation.
To determine if the translation enhancer function of the
RTS is cell type specific, translation efficiencies for GFP/
RTS RNA and GFP RNA were compared in rat B104
cells, CHO cells, and mouse oligodendrocytes in primary
culture (Table I). In CHO cells, the level of GFP fluores-
cence was more variable than in B104 cells. In some cells,
the level of GFP fluorescence was so high that the image
was saturated. These cells were not included in the calcula-
tion of translation efficiency because the intensity values
were not within the dynamic range of the assay, resulting
in an underestimate of the actual translation efficiency of
GFP/RTS RNA in CHO cells. The variability in GFP ex-
pression in CHO cells suggests that factors required for
the translation enhancer function of the RTS are ex-
pressed at variable levels in these cells. Wild-type mouse
oligodendrocytes express high levels of endogenous MBP
mRNA, which contains the RTS and which could compete
with the microinjected exogenous GFP/RTS RNA. To
minimize this potential competition, oligodendrocytes
from shiverer mutant mice, which do not express endoge-
nous MBP mRNA (Molineaux et al., 1986), were used for
these experiments. The RTS enhanced translation 4.19-
fold in B104 cells, 2.56-fold in CHO cells, and 3.38-fold in
oligodendrocytes (Table I), indicating that the translation
enhancer function is cell type independent, although the
magnitude of the effect may vary among different cell
types depending on the capacity of the translation machin-
ery or the level of endogenous RTS-containing RNAs.
 
The Translation Enhancer Function of the RTS Is
Cap Dependent
 
The experiments in Fig. 1 and Table I were performed
with monocistronic RNA containing a 5
 
9 
 
cap. The results
indicate that the RTS enhances cap-dependent translation.
To determine if IRES-dependent translation is also en-
hanced, a dicistronic mRNA encoding blue fluorescent
protein (BFP) in a cap-dependent cistron and GFP in an
IRES-dependent cistron was constructed. The RTS was
inserted into the 3
 
9
 
UTR of the dicistronic mRNA as
shown in Fig. 3 A. Translation efficiencies for BFP and
GFP were determined by microinjection into B104 cells.
Triple channel images of representative injected cells are
shown in Fig. 3 B. In the red channel, TRD intensities are
comparable for cells injected with RTS and nonRTS
RNA, indicating that the volume of injected RNA was
comparable in the two cells shown. In the green channel,
GFP intensities are comparable, indicating that IRES-
dependent translation is not enhanced by the RTS. In the
blue channel, BFP intensity is greater in the cell injected
with RTS RNA compared with the cell injected with non-
RTS RNA, indicating that cap-dependent translation is
enhanced by the RTS. Translation efficiencies for cap-
dependent and IRES-dependent translation in cells in-
jected with various amounts of RNA were calculated from
the ratio of blue to red and green to red intensities, respec-
tively. In the case of cap-dependent translation, at subsat-
urating concentrations of RTS RNA, translation efficiency
was enhanced 3.61-fold relative to nonRTS RNA (Fig. 3 C
and Table I). This is consistent with the previous results
Figure 2. Fluorescence dequenching assay for stability of GFP
RNA and GFP/RTS RNA in vivo. Fluorescein-labeled GFP
RNA (squares, solid line) or GFP/RTS RNA (diamonds, dotted
line) were microinjected into B104 cells. Cells were imaged by
digital fluorescence microscopy at different times after injection
and the intensity integrated over the whole cell area. The inte-
grated fluorescence intensity at each time point (F) divided by
the integrated intensity at time 0 (F0) is plotted versus time.
 
Table I. Translation Enhnacer Function of the RTS
 
Cell RNA Translation efficiency* Average deviation
 
B104
 
2
 
 RTS 1 0.3
B104 3
 
9
 
 RTS 4.19 2.18
B104 5
 
9
 
 RTS 4.82 1.61
B104 5
 
9
 
, 3
 
9 
 
RTS 3.27 0.96
CHO
 
2
 
 RTS 1 0.46
CHO
 
1
 
 RTS 2.56 1.5
Oligodendrocytes
 
2
 
 RTS 1 0.36
Oligodendrocytes
 
1
 
 RTS 3.38 1.8
B104 Dicistronic
Cap-dependent
 
2
 
 RTS 1 0.64
Cap-dependent
 
1
 
 RTS 3.61
 
‡
 
1.61
IRES-dependent
 
2
 
 RTS 1 0.35
IRES-dependent
 
1
 
 RTS 1.40
 
§
 
0.77
 
*Translation efficiency was determined by the ratio of GFP intensity to TRD intensity
in cells injected with subsaturating RNA (
 
,
 
10 nM).
 
‡
 
P
 
 ,
 
 0.05.
 
§
 
P
 
 
 
.
 
 0.05. 
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for cap-dependent translation of monocistronic GFP RNA
(Fig. 1 and Table I). In the case of IRES-dependent trans-
lation, translation efficiency was comparable between
RTS and nonRTS RNA (Fig. 3 D and Table I) indicating
that the translation enhancer function of the RTS is spe-
cific for cap-dependent translation and does not affect
IRES-dependent translation. In addition, the observation
that IRES-dependent translation efficiency was relatively
constant over a wide range of RNA indicates that the ma-
chinery in the cell required for IRES-dependent trans-
lation is not saturated by high concentrations of exoge-
nous RNA.
 
Both the RNA Transport and Translation Enhancer 
Functions of the RTS Are hnRNP A2 Dependent
 
HnRNP A2 binds specifically to the RTS in vitro (Hoek
et al., 1998). To determine if hnRNP A2 is required for ei-
ther the RNA transport or translation enhancer functions
of the RTS cells were treated with antisense oligonucle-
otide designed to hybridize with the translation start site
of hnRNP A2 and suppress its expression. Control cells
were treated with the corresponding sense oligonucle-
otide. The level of hnRNP A2 in oligodendrocytes was es-
timated by IF with monoclonal anti-hnRNP A2 antibody.
In untreated oligodendrocytes (Fig. 4 A), hnRNP A2 is
detected at high levels in the nucleus and also in granules
in the perikaryon and processes indicating that hnRNP A2
is present in both the nucleus and the cytoplasm. To visu-
alize the hnRNP A2 distribution in the cytoplasm, which is
lower intensity than in the nucleus, images were collected
under conditions where the nuclear signal was saturated.
Both the nuclear and cytoplasmic staining are specific for
hnRNP A2 and were not observed with control anti-
body (data not shown). In oligodendrocytes treated with
 
Figure 3.
 
Ratiometric translation assay for discistronic RNA.
(A) Structures of dicistronic RNAs. Dicistronic mRNAs encod-
ing BFP in a cap-dependent cistron and GFP in an IRES-depen-
dent cistron are shown. The RTS was inserted into the 3
 
9
 
UTR of
the dicistronic RNA. (B) Triple channel confocal microscopy of
oligodendrocytes injected with TRD and dicistronic RNA. Oligo-
dendrocytes were microinjected with TRD and either nonRTS
(left panels) or RTS-containing dicistronic RNA. After 24 h, the
cells were analyzed by triple channel confocal microscopy. A rep-
resentative cell is shown for each RNA. The TRD channel is
shown in red (i and ii), the GFP channel in green (iii and iv), and
the BFP channel in blue (v and vi). (C) Cap-dependent transla-
tion efficiency. B104 cells were microinjected with dicistronic
RNA and imaged as described in B. For each triple channel im-
age the pixel values in the three channels were integrated over
the nucleus. The red channel provides a measure of injected
TRD volume which is used to calculate intracellular RNA con-
centration. The blue channel provides a measure of expression of
BFP. The ratio of BFP intensity to TRD intensity provides a
measure of cap-dependent translation efficiency in each cell.
Open circles indicate cells injected with nonRTS RNA. Closed
circles indicate cells injected with RTS RNA. (D) IRES-depen-
dent translation efficiency. B104 cells were microinjected with di-
cistronic RNA and imaged as described in B. For each triple
channel image the pixel values in the three channels were inte-
grated over the nucleus. The red channel provides a measure of
injected TRD volume which is used to calculate intracellular
RNA concentration. The green channel provides a measure of
expression of GFP. The ratio of GFP intensity to TRD intensity
provides a measure of IRES-dependent translation efficiency in
each cell. Open circles indicate cells injected with nonRTS RNA.
Closed circles indicate cells injected with RTS RNA. 
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hnRNP A2 sense oligonucleotide (Fig. 4 B), hnRNP A2
staining in both the cytoplasm and nucleus was compara-
ble to the untreated cell indicating that hnRNP A2 expres-
sion is not affected. In oligodendrocytes treated with
hnRNP A2 antisense oligonucleotide (Fig. 4 C), hnRNP
A2 staining was reduced compared with either the un-
treated cell or the sense-treated cell, indicating that
hnRNP A2 expression was suppressed. It appears that nu-
clear hnRNP A2 is decreased to a greater extent than cy-
toplasmic hnRNP A2, suggesting that in oligodendrocytes
the nuclear pool of hnRNPA2 turns over more rapidly
than the cytoplasmic pool. Since the image for untreated
and sense-treated cells is saturated in the nuclear compart-
ment, the extent of hnRNP A2 suppression in antisense-
treated cells cannot be quantified from these images.
However, in images collected under conditions where the
nuclear compartment was not saturated (where cytoplas-
mic hnRNP A2 is not visualized; data not shown), suppres-
sion of nuclear hnRNP A2 in antisense-treated cells was
 
.
 
90%.
The effect of suppressing hnRNP A2 expression on
RNA transport in oligodendrocytes was determined by
microinjecting digoxigenin-labeled RNA into antisense-
treated cells and measuring the percentage of cells in
which the injected RNA was transported to the peripheral
processes (Fig. 4 E). GFP/RTS RNA was transported in
 
.
 
70% of untreated or sense-treated oligodendrocytes but
in 
 
,
 
40% of antisense-treated oligodendrocytes, while
GFP RNA was transported in 
 
,
 
20% of treated or un-
treated cells. These results indicate that the RNA trans-
port function of the RTS in oligodendrocytes is at least
partially dependent on hnRNP A2 expression.
The level of hnRNP A2 in B104 cells was estimated by
Western blotting with anti-hnRNP A2 antibody with anti-
ribophorin antibody as a loading control (Fig. 4 D). In un-
treated cells, hnRNP A2 is detected as a major band with
Figure 4. The effect of antisense suppression of hnRNPA2 on transport and translation of GFP RNA and GFP/RTS RNA. Oligoden-
drocytes or B104 cells were treated with antisense oligonucleotide to suppress hnRNP A2 or with sense oligonucleotide as a control.
The amount of hnRNP A2 in the cells was analyzed by either IF or Western blotting with monoclonal antibody to hnRNP A2. (A) Un-
treated oligodendrocyte stained with anti-hnRNP A2; (B) oligodendrocyte treated with sense oligonucleotide stained with anti-hnRNP
A2; (C) oligodendrocyte treated with antisense oligonucleotide stained with anti-hnRNP A2. Bar, 10 mm. (D) Western blot of B104
cells stained with anti-hnRNP A2 and anti-ribophorin I. The bands corresponding to hnRNP A2 and ribophorin are indicated. To mea-
sure RNA transport, oligodendrocytes were microinjected with digoxigenin-labeled GFP RNA or GFP/RTS RNA, and the intracellular
distribution of the injected RNA was determined by IF and confocal microscopy. The percent of cells in which the injected RNA was
transported is shown in E. Greater than 100 cells were analyzed for each treatment and for each RNA in three separate experiments. To
measure translation efficiency B104 cells were microinjected with either GFP RNA or GFP/RTS RNA and the translation efficiency
was determined for each cell as described in Fig. 1 and Table I. The mean values for cells containing less than 5 nM RNA are given in F.The Journal of Cell Biology, Volume 147, 1999 254
an apparent molecular mass of z36 kD, whereas ribo-
phorin I is detected as a band with an apparent molecular
mass of z65 kD. In some samples, the hnRNP A2 anti-
body detects two additional bands with molecular masses
slightly larger than the major band at 36 kD, which may
represent splicing variants. In cells treated with sense oli-
gonucleotide, the relative intensities of the hnRNP A2 and
ribophorin bands are comparable to untreated cells,
whereas in cells treated with antisense oligonucleotide the
intensity of the hnRNP A2 band is decreased relative to ri-
bophorin. This indicates that treatment with antisense oli-
gonucleotide suppresses hnRNP A2 expression in B104
cells.
The effect of suppressing hnRNP A2 expression on the
translation enhancer function of the RTS was determined
by measuring translation efficiencies for GFP/RTS and
GFP RNA injected into antisense-treated B104 cells at
subsaturating concentrations of RNA (Fig. 4 F). Com-
pared with GFP RNA, the translation efficiency of GFP/
RTS RNA was enhanced by 4.19-fold in untreated B104
cells, 2.0-fold in sense-treated cells, and was slightly inhib-
ited (0.94-fold) in antisense-treated cells. These results in-
dicate that the translation enhancer function of the RTS in
B104 cells is dependent on hnRNPA2 expression. The par-
tial reduction of translation efficiency in sense-treated
cells may be due to nonspecific toxic effects of the oligonu-
cleotides on the cells.
To determine if the RTS enhances translation in vitro,
GFP/RTS and GFP mRNAs were translated in a rabbit
reticulocyte lysate translation system (Fig. 5 A) and in
wheat germ extract (data not shown). In both systems,
the translation efficiencies were comparable for the two
RNAs over a range of RNA concentrations (Fig. 5 B), in-
dicating that the translation enhancer function of the RTS
requires factors that are lacking in rabbit reticulocyte ly-
sate and wheat germ extract. Addition of recombinant
hnRNP A2 to rabbit reticulocyte lysate had little effect on
translation of GFP RNA but enhanced translation of
GFP/RTS RNA in a dose-dependent manner up to a max-
imum stimulation at 1 mg (Fig. 5 C). This experiment was
repeated several times with different batches of reticulo-
cyte lysate and different preparations of hnRNP A2. As
shown in Fig. 5 D, the extent of stimulation by hnRNP A2
was variable, but in each experiment, translation of GFP/
RTS RNA was enhanced relative to GFP RNA. These re-
sults indicate that the translation enhancer function of the
RTS is hnRNP A2 dependent in rabbit reticulocyte lysate.
The variability in the extent of stimulation may reflect
variation in the activities of different preparations of re-
combinant hnRNP A2 or variation in the activities of dif-
ferent batches of reticulocyte lysate. Addition of recombi-
nant human hnRNP A2 to wheat germ extract had no
effect on translation of RTS RNA (data not shown), sug-
gesting that the interaction between hnRNP A2 and com-
ponent(s) of the translation machinery that enhances
translation in rabbit reticulocyte lysate is specific to mam-
malian systems.
Discussion
The RTS, originally identified as a cis-acting RNA traf-
ficking sequence in MBP mRNA, is shown to function as
an enhancer of cap-dependent translation in vivo and in
vitro. This represents the first specific translation enhancer
identified in a mammalian system. The translation en-
hancer function of the RTS is saturable with increasing
amounts of RNA, position, copy number, and cell type in-
dependent, and cap and hnRNP dependent. A speculative
model illustrating the proposed role of RTS/A2 cis/trans
determinants in RNA transport and translation activation
is shown in Fig. 6. According to this model, the RNA gran-
ule is transported along microtubule tracks using kinesin
as a molecular motor (Carson et al., 1997). Association of
the RNA granule cargo with the kinesin motor during
transport requires RTS/A2 determinants. Once the RNA
Figure 5. In vitro translation of GFP RNA and GFP/RTS RNA.
(A) Increasing amounts of GFP RNA or GFP/RTS RNA were
translated in rabbit reticulocyte lysate. Translation products were
visualized by SDS PAGE and autoradiography. The band corre-
sponding to GFP is indicated. (B) The intensities of the bands
corresponding to GFP in the autoradiogram shown in A were
quantitated and plotted in arbitrary translation units versus the
amount of GFP RNA (open circles) or GFP/RTS RNA (closed
circles) in the translation mixture. (C) Increasing amounts of re-
combinant hnRNPA2 were added to rabbit reticulocyte lysate
along with either GFP RNA (10 ng) or GFP/RTS (10 ng). The
translation products were analyzed by SDS-PAGE and autora-
diography. The band corresponding to GFP is indicated. (D) The
intensities of the bands corresponding to GFP in the autoradio-
graph shown in C and in three similar experiments were quanti-
tated and are plotted versus the amount of hnRNP A2 added to
the lysate. For each RNA the intensity value obtained without
hnRNP A2 was set to 1 and the other values normalized accord-
ingly and expressed as translation efficiency. GFP RNA (grey
bars); GFP/RTS RNA (black bars).Kwon et al. Translation Activation Determinants 255
granule reaches its destination, translation is activated
through interactions between RTS/A2 determinants and
components of the translation machinery, possibly eIF4E
at the 59 cap of the mRNA. This provides an explanation
for why the translation enhancer function of RTS/A2
is specific for cap-dependent translation and saturable
at high concentrations of RNA, since eIF4E is required
for cap-dependent initiation and is present in limiting
amounts in most cells (Hiremath et al., 1985). The pro-
posed interactions between RTS/A2 and kinesin during
transport and between RTS/A2 and eIF4E during transla-
tion may be direct or indirect, mediated through unknown
adapter molecules. The model does not specify a detailed
molecular mechanism for either the transport or transla-
tion enhancer functions of RTS/A2 determinants. How-
ever, several possible mechanisms are suggested by struc-
tural features of the RTS and properties of hnRNP A2.
One possible mechanism is based on sequence homol-
ogy between the RTS and the consensus Kozak sequence.
In the scanning model of eukaryotic translation initiation,
the 40S ribosomal subunit binds initially at the 59 end of
mRNA and scans in the 39 direction, initiating translation
at the first AUG codon in a favorable context (Kozak,
1989). In vertebrates, efficiently used AUG start codons
are embedded in a consensus sequence motif, termed the
Kozak sequence. As shown in Table II the consensus
Kozak sequence is partially homologous to the RTS sug-
gesting that the Kozak sequence and the RTS use similar
mechanisms for enhancing translation. There are several
caveats to this hypothesis. The Kozak sequence is position
dependent, since it always encompasses the initiation
codon, whereas the RTS is position independent, although
it does contain an AUG. In addition, the Kozak sequence
is known to interact with two proteins (z50 and 100 kD)
from HeLa cells (McBratney and Sarnow, 1996), while the
RTS interacts with hnRNP A2 (36 kD), suggesting that the
Kozak sequence and the RTS use different trans-acting
factors to enhance translation.
A second possible mechanism involves the RNA he-
lix destabilizing and annealing properties of hnRNP A2
(Monroe and Dong, 1992). The presence of secondary
structure in the 59UTR of mRNA tends to inhibit transla-
tion. After association of the eIF4F complex (consisting of
initiation factors eIF4A, eIF4E, and eIF4G) with the cap
of the mRNA, the interaction of eIF4B and the RNA heli-
case eIF4A causes ATP-dependent melting of secondary
structure in the 59UTR. This activity is believed to facili-
tate binding of the 40S preinitiation complex to the
mRNA. Recently, eIF4B was shown to stimulate eIF4A-
mediated melting of RNA secondary structure in vitro
(Altman et al., 1995). In a similar fashion, binding of
hnRNP A2 to the RTS might promote unwinding of sec-
ondary structure in the mRNA to reduce a kinetic barrier
to formation of the translation initiation complex. Melting
of RNA secondary structure by hnRNP A2 could facilitate
binding of the 40S preinitiation complex to the mRNA
and scanning the 59UTR in translation initiation. Besides
melting secondary structures, the RNA annealing activity
of hnRNP A2 could also play a role in recognition of the
start codon. Base pairing between the AUG initiation
codon and the anticodon of the initiator tRNA, which is a
major determinant for AUG codon recognition, could be
facilitated by the RNA annealing activity of hnRNP A2,
thus, enhancing translation efficiency.
A third possible mechanism involves potential eIF4E-
binding motifs in hnRNP A2. A recently determined x-ray
structure of murine eIF4E, bound to a cap analogue (7-
methyl-GDP), provides a basis for analyzing contacts be-
tween eIF4E and proteins that interact with eIF4E during
translation initiation (Marcotrigiano et al., 1997). The
eIF4E-binding sites in eIF4E-binding proteins, 4E-BP1,
4E-BP2, and eIF4G, share a common motif, Y-X-X-X-X-
L-L, suggesting that these proteins compete for the same
site in eIF4E. The RBD1 domain of hnRNP A2 contains a
peptide sequence, Y-E-Q-W-G-K-L, which is similar to the
putative eIF4E binding motif and might be involved in
Figure 6. Model for RTS/hnRNP A2 functions in RNA transport
and translation. RTS-containing mRNA is shown in yellow with
the coding region in orange. hnRNP A2 is shown as a light blue
sphere. Core granule components (aminoacyl tRNA synthetases,
elongation factors) are shown as a green sphere. A microtubule is
shown in magenta. Kinesin is shown in dark blue. eIF4E is shown
in grey. Ribosomes are shown in red. Nascent polypeptide chains
are shown in green. Specific molecular components are not
drawn to scale and juxtaposition of specific components does not
necessarily imply direct molecular interactions.
Table II. Homology between the RTS and the Kozak
Consensus Sequence
RTS* 59 GCCAAGGAGCCAGAGAGCAUG 39
Kozak‡ 59 GCC GCC ACCAUGG 39
*Mouse MBP mRNA RTS (Ainger et al., 1997).
‡Vertebrate Kozak consensus sequence (Kozak, 1987, 1989) with nucleotides homol-
ogous to the RTS indicated in bold.The Journal of Cell Biology, Volume 147, 1999 256
eIF4E binding. This could affect formation of the initia-
tion complex. It will be important to determine whether
there is direct biochemical interaction between hnRNP A2
and eIF4E.
Whatever the molecular mechanism(s) for translation
activation by the RTS and hnRNP A2, the fact that the
same cis/trans determinants that mediate multiple steps in
the RNA trafficking pathway also enhance translation un-
derscores the integral role of translation regulation in
RNA trafficking. The RTS and hnRNP A2 comprise the
first translation enhancer identified in a mammalian sys-
tem. This may prove useful in applications where maximal
expression is critical.
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